| 查看: 82 | 回复: 1 | |||
| 当前主题已经存档。 | |||
[交流]
实在找不到，急用！
|
|||
|
Preclinical safety studies of cefmetazole. Moe JB, Piper RC, Tanase H, Sotani K, Manabe J. Upjohn Company, Kalamazoo, Michigan 49001. In order to assess the safety of cefmetazole, preclinical multiple-dose parenteral studies, varying from one to three months in length, were conducted in Sprague-Dawley rats and beagle dogs. Although the largest doses used were in multiples of several times the weight-adjusted doses intended for humans, cefmetazole was generally well tolerated. The principal adverse effect noted in the adult rats receiving the largest doses (2000 and 2500 mg/kg/day) of cefmetazole was slight elevation of serum alanine aminotransferase. Infant rats injected subcutaneously with 300 mg/kg/day or more of cefmetazole for 35 consecutive days had reversible reductions in testicular weight and maturation of spermatogenesis, but not lasting discernible effect on reproductive function. The most consistent effects of longterm multiple dosing with cefmetazole in dogs consisted of vomiting and retching during dosing and reversible haematological changes (mild regenerative anaemia, positive Coombs' test, clinically-silent thrombocytopenia) in a number of the dogs. These findings supported the interpretation that cefmetazole was acceptably safe for clinical studies in humans. PMID: 2722719 [PubMed - indexed for MEDLINE] 我的E-MAIL：zw1159@163.com |
回复此楼» 猜你喜欢
计算机、0854电子信息（085401-058412）调剂
已经有4人回复
-
基金申报
已经有3人回复
-
国自然申请面上模板最新2026版出了吗？
已经有9人回复
-
溴的反应液脱色
已经有6人回复
-
纳米粒子粒径的测量
已经有7人回复
-
常年博士招收(双一流，工科)
已经有4人回复
-
推荐一本书
已经有10人回复
-
参与限项
已经有5人回复
-
有没有人能给点建议
已经有5人回复
-
假如你的研究生提出不合理要求
已经有12人回复
|
本帖内容被屏蔽 |
2楼2006-09-25 11:49:34